EGFR activity enhances tumor growth, invasion, and metastasis, thus conferring a more aggressive phenotype, and further supporting the epithelial–mesenchymal plasticity model in patients with sarcoma: indeed invasion and dissemination in non-epithelial tumors could be due to EGFR expression on CTCs. The gene discussed is EGFR; the disease is neoplasm.